DailyDoctor Archive Specialties Get app
Back to the 19 October 2026 edition

Clinical update · 01 of 05

Deep neuromuscular block reduced three-month chronic pain after lumbar fusion

Deep neuromuscular block may lower early chronic pain after lumbar fusion; consider it, with quantitative monitoring and planned reversal.

Design
Single-centre randomised clinical trial
Population
180 adults having posterior lumbar interbody fusion
Primary outcome
Chronic postsurgical pain at 3 months
Effect
19.1% vs 34.8%, RR 0.6 (0.3-0.9); 6 months RR 0.8 (0.4-1.5)

A single-centre randomised trial (Anesthesia & Analgesia, 7 October 2026) assigned 180 patients having posterior lumbar interbody fusion to deep or moderate neuromuscular block; 178 were analysed.

Chronic postsurgical pain at three months, the primary outcome, was less common with deep block (19.1% vs 34.8%; RR 0.6, 95% CI 0.3-0.9). By six months the difference was smaller and not significant (14.6% vs 19.1%; RR 0.8, 0.4-1.5). Deep block was also associated with lower early pain scores, less opioid use, lower muscle injury markers on day one and better-preserved paraspinal muscle on MRI at six months.

The plausible mechanism is less forceful retraction against relaxed paraspinal muscle. This is one centre and the benefit faded by six months, so it is a reason to consider deep block for this operation rather than a new standard. Deep block requires quantitative monitoring and a reliable reversal plan.

  • Consider deep neuromuscular block for posterior lumbar fusion where retraction is extensive
  • Use quantitative neuromuscular monitoring whenever deep block is maintained
  • Plan reversal and confirm a train-of-four ratio of at least 0.9 before extubation
  • Track chronic pain at three and six months in your own spine service

Why it matters

It suggests an intraoperative choice the anaesthetist controls may influence pain months later.

Don't overread it

Single-centre, with the benefit no longer significant at six months.

The statistics, in plain English

A risk ratio of 0.6 at three months means about 40% fewer patients had chronic pain, with an interval (0.3-0.9) that excludes no effect. At six months the interval (0.4-1.5) crosses 1.0, so the longer-term benefit is uncertain. The biomarker and MRI findings are secondary and support, rather than prove, the mechanism.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

acutepainchronicpainicusedationperioperativeanaesmonitoringpaedanaesairwaymgmt

Tomorrow morning, before your first patient

One edition a day for anaesthesiology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app